MKC: The Market Hates the Deal. The Core Business Is Holding Up.McCormick & Company, IncorporatedBATS:MKCstouflacrucoMKC has fallen almost 50% from its highs, with shares now around $55. Normally, I would expect that kind of drawdown to accompany a collapsing consumer franchise. Instead, McCormick just delivered higher margins, double-digit adjusted earnings growth and reaffirmed guidance. The elephant in the room is something else entirely: the proposed combination with Unilever Foods will fundamentally transform McCormick. The Master Buy Scanner V2 sees the valuation reset, but the monthly reversal still isn't confirmed. Master Buy Scanner V2 — Monthly Score: 2/3 Action: WATCH Decision: WATCH Entry quality: OK — 60% Position size: NONE — 0% Top recent: YES WT cross: NO Band 1: RED Combined: GREEN 6/10 Bands synchronized: NO Cycle: ACTIVE WT1 / WT2: -57.57 / -56.13 Momentum is already extremely depressed and the Combined signal has improved to 6/10. But the actual trigger is missing: no bullish WT cross, red Band 1 and no synchronization. The advanced model is more encouraging at 11/14, with the lifecycle moving into STABILIZE and recovery already classified as confirmed. So this looks more like accumulation beginning underneath the surface than a finished bottom. The latest quarter was stronger than the chart suggests Q2 FY2026 delivered: Net sales: $1.94B, +16.7% Organic sales: +1.7% Gross margin: 40.2%, +270 bps Adjusted operating income: $336M, +30% Adjusted EPS: $0.80, +15.9% The headline revenue growth needs context: McCormick de Mexico contributed roughly 12 percentage points and currency added another 2.7 points. Underlying volume/mix actually declined 0.5%, while pricing contributed 2.2%. So the core business is stable rather than booming. But profitability is improving. Even excluding a tariff refund that boosted gross margin by roughly 140 bps, underlying gross margin still expanded around 130 bps. That is important for a mature staples business. The Unilever deal changes everything McCormick is preparing to combine with Unilever's Foods business, bringing brands such as Hellmann's and Knorr alongside McCormick, Frank's RedHot, French's, Cholula and the rest of its existing portfolio. The proposed transaction values Unilever Foods at approximately $44.8B enterprise value, and the combined company would have around $20B in FY2025 revenue with an estimated 21% operating margin. Closing is currently expected around mid-2027, subject to approvals. Management expects: Approximately $600M of annual net cost synergies Mid-to-high single-digit adjusted EPS accretion in the first 12 months Mid-to-high teens EPS accretion by Year 3 Strategically, I understand the logic. McCormick is moving from being primarily a spices-and-condiments company into a global flavor platform with enormous distribution scale. But this is also exactly why the market is nervous. Execution and leverage are now the real risks Unilever is set to receive $15.7B in cash as part of the transaction structure, meaning McCormick will take on substantial financing obligations. Management expects the combined company to generate enough cash to deploy roughly $1.5–2.0B toward debt reduction during the first two years, targeting leverage around 3x and eventually 2–3x. That makes this far more complicated than simply saying: McCormick fell 50%, therefore it is cheap. The investment case now depends heavily on management successfully integrating a business substantially larger than McCormick itself. Potential upside is enormous if the synergy assumptions work. The downside is that leverage, integration costs and weak food-category growth could keep the valuation depressed for years. One scanner number I would NOT trust blindly The scanner shows an earnings-price multiple around 9.2x. That looks extremely cheap — but it is misleading right now. McCormick recorded an $866.8M accounting gain from remeasuring its previously held stake in McCormick de Mexico during H1 2026. That dramatically inflated reported GAAP earnings. Management's actual FY2026 adjusted EPS guidance is $3.05–$3.13. At roughly $55, that means the stock is closer to 18x adjusted forward earnings, not 9x. That's still far more reasonable than McCormick's historical premium valuation — but it isn't distressed deep value. The rest of the scanner remains interesting: Valuation score: 5.5/7 Cash yield: 6.86% Business-price: 12.02 Debt/equity: 0.71 Business quality: 2.5/3 Growth is modest — and that's the key question The scanner gives growth only 2.5/4: Future profit growth: 2.9% 3Y profit growth: 5.1% 3Y sales growth: 2.51% Management similarly expects only 1–3% organic sales growth in FY2026, although reported growth should be 13–17% because of McCormick de Mexico. Adjusted operating income is expected to rise 16–20%. That is why the Unilever combination matters so much. Without it, McCormick looks like a high-quality but relatively slow-growing consumer staples company. With it, management is betting that scale + distribution + margin synergies + stronger global brands can restart the compounding story. Key technical levels Immediate support: $48–52 Major support: $45–47 Current zone: ~$55 First resistance: $58–60 Recovery confirmation: $64–68 Major resistance: $72–75 Structural recovery: $80+ The monthly oscillator is already sitting near an extreme long-term oversold zone. What is missing is simple: WT cross + Band 1 green + synchronization. If those arrive while the stock holds the $50 area, the technical picture changes considerably. My classification: TRANSFORMATION WATCH This isn't really a conventional defensive-stock setup anymore. McCormick now combines: Powerful global brands Improving underlying margins 16% adjusted EPS growth last quarter Better valuation Extremely depressed momentum A potentially transformational merger Significant synergy potential But also: Slow organic growth Huge integration complexity Material future leverage No monthly WT cross No synchronized BUY signal The stock appears to be pricing in a substantial amount of skepticism toward the Unilever transaction. That could eventually create the opportunity. But given the scale of the deal, I want confirmation rather than simply assuming a 50% decline has made MKC cheap enough. Current verdict: WATCH — the business is stabilizing, but the merger has changed the risk profile. What would you do? A) Start small around $55 B) Wait for the monthly BUY signal C) Wait for more clarity on the Unilever integration Master Buy Scanner V2: Not financial advice.